NCT06439628View on ClinicalTrials.gov

ARISE-A Chinese Real-world Study of Rimegepant for the Acute Treatment of Migraine

RecruitingOBSERVATIONAL
Enrollment

3,000

Participants

Timeline

Start Date

September 27, 2024

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2027

Conditions
Migraine
Interventions
DRUG

Rimegepant

patients take rimegepant to treat migraine attack as needed

Trial Locations (3)

Unknown

RECRUITING

Chinese PLA General Hospital, Beijing

RECRUITING

Peking University People's Hospital, Beijing

RECRUITING

The Second Affiliated Hospital Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

Chinese PLA General Hospital

OTHER